Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biomolecules ; 10(1)2019 12 23.
Article in English | MEDLINE | ID: mdl-31878100

ABSTRACT

Alignment-free (AF) methodologies have increased in popularity in the last decades as alternative tools to alignment-based (AB) algorithms for performing comparative sequence analyses. They have been especially useful to detect remote homologs within the twilight zone of highly diverse gene/protein families and superfamilies. The most popular alignment-free methodologies, as well as their applications to classification problems, have been described in previous reviews. Despite a new set of graph theory-derived sequence/structural descriptors that have been gaining relevance in the detection of remote homology, they have been omitted as AF predictors when the topic is addressed. Here, we first go over the most popular AF approaches used for detecting homology signals within the twilight zone and then bring out the state-of-the-art tools encoding graph theory-derived sequence/structure descriptors and their success for identifying remote homologs. We also highlight the tendency of integrating AF features/measures with the AB ones, either into the same prediction model or by assembling the predictions from different algorithms using voting/weighting strategies, for improving the detection of remote signals. Lastly, we briefly discuss the efforts made to scale up AB and AF features/measures for the comparison of multiple genomes and proteomes. Alongside the achieved experiences in remote homology detection by both the most popular AF tools and other less known ones, we provide our own using the graphical-numerical methodologies, MARCH-INSIDE, TI2BioP, and ProtDCal. We also present a new Python-based tool (SeqDivA) with a friendly graphical user interface (GUI) for delimiting the twilight zone by using several similar criteria.


Subject(s)
Computational Biology/methods , Computer Graphics , Sequence Analysis, Protein , Sequence Homology , Amino Acid Sequence
2.
Curr Pharm Des ; 22(33): 5065-5071, 2016.
Article in English | MEDLINE | ID: mdl-27165163

ABSTRACT

BACKGROUND: The Ribonuclease III (RNase III) enzymatic class is involved in many important biological processes from bacteria to higher eukaryotes. Consequently, they have been useful as drug-target candidates for drug development. Despite their high molecular diversity, RNases III share common structural and catalytic features and some degree of enzymatic activity. However, the role of accessory domains as key determinants of substrate selectivity and over the biological function of each RNase III type is still under study. RESULTS: The in vitro enzymatic activity of three RNase III members from class I (Escherichia coli RNase III, Schizosaccharomyces pombe Pac1 and Saccharomyces cerevisiae Rntp1) and the human Drosha placed in class II was revisited against four different substrates. These two RNase III classes comprise members showing different domain organization. Enzymatic activity differences were found among members of the class I, which were even higher when the human Drosha (class II) was tested. The substrate promiscuity of the E. coli RNase III was corroborated in vivo through its expression in S. cerevisiae, as reported previously, but was extended here to Pichia pastoris. The putative molecular mechanisms contributing for the lethal effect of the heterologous RNase III on the yeast lives were deeply discussed. CONCLUSION: The new generated biochemical data integrated with previous available information affirmed that RNases III substrate specificity as well as their cellular biological role is highly influenced by its protein structure architecture. This fact also allowed drawing evolutionary links between RNase III members from their structural and substrate specificity differences.


Subject(s)
Ribonuclease III/metabolism , Animals , Escherichia coli/enzymology , Humans , Ribonuclease III/chemistry , Saccharomyces cerevisiae/enzymology , Schizosaccharomyces/enzymology , Substrate Specificity
3.
Curr Pharm Des ; 22(21): 3082-96, 2016.
Article in English | MEDLINE | ID: mdl-26932160

ABSTRACT

BACKGROUND: Virtual Screening methodologies have emerged as efficient alternatives for the discovery of new drug candidates. At the same time, ensemble methods are nowadays frequently used to overcome the limitations of employing a single model in ligand-based drug design. However, many applications of ensemble methods to this area do not consider important aspects related to both virtual screening and the modeling process. During the application of ensemble methods to virtual screening the proper validation of the models in virtual screening conditions is often neglected. No analysis of the diversity of the ensemble members is performed frequently or no considerations regarding the applicability domain of the base models are being made. METHODS: In this research, we review basic concepts and definitions related to virtual screening. We comment recent applications of ensemble methods to ligand-based virtual screening and highlight their advantages and limitations. RESULTS: Next, we propose a method based on genetic algorithms optimization for the generation of virtual screening tailored ensembles which address the previously identified problems in the current applications of ensemble methods to virtual screening. CONCLUSION: Finally, the proposed methodology is successfully applied to the generation of ensemble models for the ligand-based virtual screening of dual target A2A adenosine receptor antagonists and MAO-B inhibitors as potential Parkinson's disease therapeutics.


Subject(s)
Adenosine A2 Receptor Antagonists/pharmacology , Drug Evaluation, Preclinical/methods , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Parkinson Disease/drug therapy , Receptor, Adenosine A2A/metabolism , Adenosine A2 Receptor Antagonists/chemistry , Humans , Ligands , Monoamine Oxidase Inhibitors/chemistry , Parkinson Disease/metabolism
4.
Biomed Res Int ; 2015: 748681, 2015.
Article in English | MEDLINE | ID: mdl-26605337

ABSTRACT

Orthology detection requires more effective scaling algorithms. In this paper, a set of gene pair features based on similarity measures (alignment scores, sequence length, gene membership to conserved regions, and physicochemical profiles) are combined in a supervised pairwise ortholog detection approach to improve effectiveness considering low ortholog ratios in relation to the possible pairwise comparison between two genomes. In this scenario, big data supervised classifiers managing imbalance between ortholog and nonortholog pair classes allow for an effective scaling solution built from two genomes and extended to other genome pairs. The supervised approach was compared with RBH, RSD, and OMA algorithms by using the following yeast genome pairs: Saccharomyces cerevisiae-Kluyveromyces lactis, Saccharomyces cerevisiae-Candida glabrata, and Saccharomyces cerevisiae-Schizosaccharomyces pombe as benchmark datasets. Because of the large amount of imbalanced data, the building and testing of the supervised model were only possible by using big data supervised classifiers managing imbalance. Evaluation metrics taking low ortholog ratios into account were applied. From the effectiveness perspective, MapReduce Random Oversampling combined with Spark SVM outperformed RBH, RSD, and OMA, probably because of the consideration of gene pair features beyond alignment similarities combined with the advances in big data supervised classification.


Subject(s)
Algorithms , Databases, Nucleic Acid , Genes, Fungal , Sequence Analysis, DNA/methods , Yeasts/genetics
5.
Toxicol Sci ; 136(2): 548-65, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24068674

ABSTRACT

Ionic liquids (ILs) possess a unique physicochemical profile providing a wide range of applications. Their almost limitless structural possibilities allow the design of task-specific ILs. However, their "greenness," specifically their claimed relative nontoxicity has been frequently questioned, hindering their REACH registration processes and, so, their final application. Because the vast majority of ILs is yet to be synthesized, the development of chemoinformatics tools efficiently profiling their hazardous potential becomes essential. In this work, we introduce a reliable, predictive, simple, and chemically interpretable Classification and Regression Trees (CART) classifier, enabling the prioritization of ILs with a favorable cytotoxicity profile. Besides a good predictive capability (81% or 75% or 83% of accuracy or sensitivity or specificity in an external evaluation set), the other salient feature of the proposed cytotoxicity CART classifier is their simplicity and transparent chemical interpretation based on structural molecular fragments. The essentials of the current structure-cytotoxicity relationships of ILs are faithfully reproduced by this model, supporting its biophysical relevance and the reliability of the resultant predictions. By inspecting the structure of the CART, several moieties that can be regarded as "cytotoxicophores" were identified and used to establish a set of SAR trends specifically aimed to prioritize low-cytotoxicity ILs. Finally, we demonstrated the suitability of the joint use of the CART classifier and a group fusion similarity search as a virtual screening strategy for the automatic prioritization of safe ILs disperse in a data set of ILs of moderate to very high cytotoxicity.


Subject(s)
Ionic Liquids/chemistry , Ionic Liquids/toxicity , Reproducibility of Results , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...